Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 457Pancreatic Neoplasms 364Stomach Neoplasms 246Carcinoma, Hepatocellular 231Carcinoma, Non-Small-Cell Lung 165Colonic Neoplasms 146Esophageal Neoplasms 133Neoplasms 115Neoplasm Metastasis 115Ovarian Neoplasms 111Rectal Neoplasms 107Liver Neoplasms 101Breast Neoplasms 99Lung Neoplasms 79Melanoma 76Squamous Cell Carcinoma of Head and Neck 70Gastrointestinal Neoplasms 58Endometrial Neoplasms 58Carcinoma, Renal Cell 54Uterine Cervical Neoplasms 52Cholangiocarcinoma 52Biliary Tract Neoplasms 52Triple Negative Breast Neoplasms 49Head and Neck Neoplasms 48Sarcoma 46Prostatic Neoplasms 45Esophageal Squamous Cell Carcinoma 39Urinary Bladder Neoplasms 34Small Cell Lung Carcinoma 31Carcinoma 29

Interventions

Mitomycin 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Recurrence Hepatocellular Carcinoma × Gastrointestinal × Clear all
NCT02638857 2016-01-01

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Second Military Medical University

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Recurrence Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡